Cargando…
Synapsin II Is Involved in the Molecular Pathway of Lithium Treatment in Bipolar Disorder
Bipolar disorder (BD) is a debilitating psychiatric condition with a prevalence of 1–2% in the general population that is characterized by severe episodic shifts in mood ranging from depressive to manic episodes. One of the most common treatments is lithium (Li), with successful response in 30–60% o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286475/ https://www.ncbi.nlm.nih.gov/pubmed/22384280 http://dx.doi.org/10.1371/journal.pone.0032680 |